BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28580061)

  • 1. Disseminated Peritoneal Leiomyomatosis Status Post Laparoscopic Hysterectomy with Morcellation.
    Anand N; Handler M; Khan A; Wagreich A; Calhoun S
    J Radiol Case Rep; 2016 Dec; 10(12):12-18. PubMed ID: 28580061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case of Simultaneous Benign Metastasizing Leiomyomas and Disseminated Peritoneal Leiomyomatosis Following Endoscopic Power Morcellation for Uterine Disease.
    Park BY; Leslie KO; Chen L; Vaszar LT; Cornella JL
    Female Pelvic Med Reconstr Surg; 2017; 23(1):e1-e3. PubMed ID: 27748666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic Dissection of Extensive Secondary Disseminated Peritoneal Leiomyomatosis.
    Mairaing K; Huang KG
    J Minim Invasive Gynecol; 2018; 25(4):580-581. PubMed ID: 29032253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iatrogenic parasitic leiomyoma and leiomyomatosis peritonealis disseminata following uterine morcellation.
    Lu B; Xu J; Pan Z
    J Obstet Gynaecol Res; 2016 Aug; 42(8):990-9. PubMed ID: 27125448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated peritoneal leiomyomatosis postmorcellated resection of uterine leiomyomatous tissue.
    Sekulic M; Moench L; Movahedi-Lankarani S
    APMIS; 2016 Dec; 124(12):1063-1071. PubMed ID: 27649643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Benign intraperitoneal metastatic leiomyomatosis: A case report].
    García P; Errázuriz JI; Fernández C; Arteaga E
    Rev Med Chil; 2017 Feb; 145(2):255-259. PubMed ID: 28453593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical cytoreduction for disseminated benign disease after open power uterine morcellation.
    Ramos A; Fader AN; Long Roche K
    Obstet Gynecol; 2015 Jan; 125(1):99-102. PubMed ID: 25560110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated peritoneal leiomyomatosis: a devastating sequelae of unconfined laparoscopic morcellation.
    Tan HL; Koh YX; Chew MH; Wang J; Lim JSK; Leow WQ; Lee SY
    Singapore Med J; 2019 Dec; 60(12):652-654. PubMed ID: 31889207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated peritoneal leiomyomatosis after uterine artery embolization, laparoscopic surgery, and high intensity focused ultrasound for uterine fibroids:a case report.
    Liu C; Chen B; Tang X; Xiong Y
    Int J Hyperthermia; 2020; 37(1):925-928. PubMed ID: 32752969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DISSEMINATED PERITONEAL LEYOMYOMATOSIS AFTER LAPAROSCOPIC MORCELLATION--A CASE REPORT].
    Gincheva D; Nikolova M
    Akush Ginekol (Sofiia); 2016; 55(3):36-9. PubMed ID: 27514144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical removal of multiple mesenteric fibroids (Kg 4,500) by abdominal spread of previous laparoscopic uterine myomectomy.
    Leanza V; Gulino FA; Leanza G; Zarbo G
    G Chir; 2015; 36(1):32-5. PubMed ID: 25827668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated peritoneal leiomyomatosis: an unusual complication of laparoscopic myomectomy.
    Kumar S; Sharma JB; Verma D; Gupta P; Roy KK; Malhotra N
    Arch Gynecol Obstet; 2008 Jul; 278(1):93-5. PubMed ID: 18193441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of disseminated peritoneal leiomyomatosis after two laparoscopic procedures due to uterine fibroids.
    Ciebiera M; Słabuszewska-Jóźwiak A; Zaręba K; Jakiel G
    Wideochir Inne Tech Maloinwazyjne; 2017; 12(1):110-114. PubMed ID: 28446940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morcellation of occulted sarcomas during laparoscopic myomectomy and hysterectomy for patients with large fibroid uterus.
    Tinelli A; Farghaly SA
    Minerva Ginecol; 2018 Feb; 70(1):84-88. PubMed ID: 28975775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parasitic leiomyomas: a systematic review.
    Lete I; González J; Ugarte L; Barbadillo N; Lapuente O; Álvarez-Sala J
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():250-9. PubMed ID: 27359081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A medical-legal review of power morcellation in the face of the recent FDA warning and litigation.
    Ton R; Kilic GS; Phelps JY
    J Minim Invasive Gynecol; 2015; 22(4):564-72. PubMed ID: 25623369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in Surgical Practice for Women With Leiomyomas After the U.S. Food and Drug Administration Morcellator Safety Communication.
    Clark NM; Schembri M; Jacoby VL
    Obstet Gynecol; 2017 Nov; 130(5):1057-1063. PubMed ID: 29016511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the Future of Open Intraperitoneal Power-Morcellation of Fibroids?
    Parker WH; Pritts EA; Olive DL
    Clin Obstet Gynecol; 2016 Mar; 59(1):73-84. PubMed ID: 26670834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study.
    Multinu F; Casarin J; Tortorella L; Huang Y; Weaver A; Angioni S; Melis GB; Mariani A; Stewart EA; Laughlin-Tommaso SK
    Am J Obstet Gynecol; 2019 Feb; 220(2):179.e1-179.e10. PubMed ID: 30447212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.